New York, NY -- (SBWIRE) -- 01/21/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Liberator Medical Holdings Inc (NYSEMKT:LBMH), Bacterin International Holdings Inc (NYSEMKT:BONE), Prosensa Holding NV (NASDAQ:RNA), PDL BioPharma Inc (NASDAQ:PDLI)
Liberator Medical Holdings Inc (NYSEMKT:LBMH) showed a volume of 1.25 million shares by the end of last trade whereas the average volume of the stock remained 604,526.00 shares. The stock opened the session at $5.65 but then moved to $5.94. At that price, the stock showed a positive performance of 6.64%. Liberator Medical Holdings, Inc. is a national direct-to-consumer provider of medical supplies to Medicare-eligible seniors. The Company’s wholly owned subsidiary, Liberator Medical Supply, Inc. (LMS), is a direct-to-consumer, provider of Medicare Part B Benefits.
Will LBMH Continue To Move Higher? Find Out Here
Bacterin International Holdings Inc (NYSEMKT:BONE) opened the session at $0.64 and closed the session at $0.760. The stock showed a positive performance of 16.92% in previous trading session. Traded with volume of 1.24 million shares in the prior session and the average volume of the stock remained 280,451.00 shares. Bacterin International Holdings, Inc. is a United States-based company, which manufactures and markets biologics products. It operates as medical device company and accredited tissue bank that designs and markets advanced medical products.
For How Long BONE will fight for Profitability? Read This Trend Analysis report
Prosensa Holding NV (NASDAQ:RNA) opened the session at $6.94 and closed the session at $6.34. The stock showed a negative performance of -7.91% in previous trading session. Traded with volume of 1.23 million shares in the prior session and the average volume of the stock remained 554,219.00 shares. Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders.
Why Should Investors Buy RNA After the Recent Fall? Just Go Here and Find Out
PDL BioPharma Inc (NASDAQ:PDLI) the stock advanced 0.56% and finished the session at $8.97. Traded with volume of 1.22 million shares in the prior session and the average volume of the stock remained 2.30 million shares. The beta of the stock remained 0.60. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Will PDLI Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)